GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » EV-to-EBITDA

ArcticZymes Technologies ASA (FRA:B4V) EV-to-EBITDA : -814.28 (As of May. 16, 2025)


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, ArcticZymes Technologies ASA's enterprise value is €52.11 Mil. ArcticZymes Technologies ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.06 Mil. Therefore, ArcticZymes Technologies ASA's EV-to-EBITDA for today is -814.28.

The historical rank and industry rank for ArcticZymes Technologies ASA's EV-to-EBITDA or its related term are showing as below:

FRA:B4V' s EV-to-EBITDA Range Over the Past 10 Years
Min: -843.52   Med: 40.65   Max: 174.96
Current: 115.22

During the past 13 years, the highest EV-to-EBITDA of ArcticZymes Technologies ASA was 174.96. The lowest was -843.52. And the median was 40.65.

FRA:B4V's EV-to-EBITDA is ranked worse than
95.59% of 499 companies
in the Biotechnology industry
Industry Median: 7.15 vs FRA:B4V: 115.22

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-16), ArcticZymes Technologies ASA's stock price is €1.385. ArcticZymes Technologies ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was €0.001. Therefore, ArcticZymes Technologies ASA's PE Ratio (TTM) for today is 1,385.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


ArcticZymes Technologies ASA EV-to-EBITDA Historical Data

The historical data trend for ArcticZymes Technologies ASA's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA EV-to-EBITDA Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.65 72.41 72.33 62.27 29.71

ArcticZymes Technologies ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.96 74.15 150.68 29.71 -840.29

Competitive Comparison of ArcticZymes Technologies ASA's EV-to-EBITDA

For the Biotechnology subindustry, ArcticZymes Technologies ASA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's EV-to-EBITDA falls into.


;
;

ArcticZymes Technologies ASA EV-to-EBITDA Calculation

ArcticZymes Technologies ASA's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=52.114/-0.064
=-814.28

ArcticZymes Technologies ASA's current Enterprise Value is €52.11 Mil.
ArcticZymes Technologies ASA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ArcticZymes Technologies ASA  (FRA:B4V) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

ArcticZymes Technologies ASA's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.385/0.001
=1,385.00

ArcticZymes Technologies ASA's share price for today is €1.385.
ArcticZymes Technologies ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.001.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


ArcticZymes Technologies ASA EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


ArcticZymes Technologies ASA Business Description

Traded in Other Exchanges
Address
Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.

ArcticZymes Technologies ASA Headlines

No Headlines